Correlation Engine 2.0
Clear Search sequence regions


  • 4 pba (2)
  • bromide (1)
  • cell cycle (1)
  • dementia (1)
  • flow (1)
  • glycogen (3)
  • GRP78 (1)
  • GSK 3β (5)
  • GSK3B (1)
  • humans (1)
  • impairment (1)
  • protein human (1)
  • reticulum (8)
  • tau Proteins (2)
  • western blot (1)
  • zeaxanthin (8)
  • Sizes of these terms reflect their relevance to your search.

    Alzheimer's disease (AD) characterized by neurofibrillary tangles caused by hyperphosphorylated tau is the most common cause of dementia. Zeaxanthin (Zea), derived from fruits and vegetables, may reduce the risk of AD. Endoplasmic reticulum stress (ERS) might cause memory impairment in AD. Here, we studied protective role of Zea on the relationship among ERS, activity of glycogen synthase kinase 3β (GSK-3β, tau phosphorylated kinase), and p-Tau (Ser 396 and Thr 231). The results were obtained in non-RA and RA group by using different treatment, such as 9-cis-retinoic acid (RA), TM (ERS inducer), Zea, 4-PBA (ERS inhibitor), and SB216763 (GSK-3β inhibitor). The methods included flow cytometry and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] for the detections of cell cycle and cell viability and western blot as a third measure of proteins in relation to ERS and tau phosphorylation. We have collected and analyzed all the data that suggested application of drugs for the treatment in non-RA and RA group. Zea displays its protection on TM-induced cell injury, upregulation of GRP78 expression, and change of GSK-3β activity and tau phosphorylation when 4-PBA and SB216763 interfere with the process. These studies indicated that Zea is in vicious circle in ERS, GSK-3β, and tau phosphorylation, and further reflect its potential value in AD.

    Citation

    Li-Na Zhang, Meng-Jie Li, Ying-Hui Shang, Yun-Ru Liu, Huang Han-Chang, Feng-Xue Lao. Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3β Activation. Journal of Alzheimer's disease : JAD. 2022;86(1):191-204

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35034906

    View Full Text